Search - tctmd.com

Displaying 1 - 20 of 20

Sort: Relevancy | Date

News Conference News EuroPCR 2025

Myval Noninferior to Other THVs at 1 Year, but Questions Persist

L.A. McKeown

May 21, 2025

News Conference News EuroPCR 2025

Early TAVI Improves Prognosis in Asymptomatic AS No Matter the Extent of Cardiac Damage

Yael L. Maxwell

May 21, 2025

Presentation EuroPCR 2024

Early outcomes of a randomised non-inferiority trial comparing TAVI devices: the LANDMARK trial

Presenter: Patrick Serruys

May 15, 2024

News Conference News EuroPCR 2024

Myval Matches Contemporary TAVI at 30 Days, but Do More Sizes Matter?

Shelley Wood

May 15, 2024

Presentation EuroPCR 2024

Short Methodology Insight - LANDMARK

Presenter: Davide Capodanno

May 14, 2024

News Conference News EuroPCR 2023

Up and Away: TAVI Early Discharge Protocols Safely Cut Length of Stay

Michael O'Riordan

May 18, 2023

News Conference News EuroPCR 2023

Five-Year PORTICO IDE Data Reassure on Outcomes, Hemodynamics

Michael O'Riordan

May 17, 2023

News Conference News EuroPCR 2022

Self-Expanding TAVI Valves Offer Best Results in Small Failed Aortic Bioprostheses: LYTEN

Caitlin E. Cox

May 27, 2022

News Conference News EuroPCR 2022

Better Durability With Self-Expanding TAVI? Clues From UK TAVI

Shelley Wood

May 18, 2022

News Conference News EuroPCR 2022

Changes in Cardiac Damage After AVR Tied to 2-Year Outcomes

Caitlin E. Cox

May 17, 2022

News Conference News EuroPCR 2020

Novel Ultrasound Therapy Shows Promise for Patients Unfit for TAVR, SAVR

L.A. McKeown

July 01, 2020

News Conference News EuroPCR 2019

Allegra TAVR System Feasible for Treating Degenerated Surgical Valves

Michael O'Riordan

May 29, 2019

News Conference News EuroPCR 2019

Longer Follow-up ‘Reassuring’ for New-Onset LBBB After TAVR—With Caveats

Michael O'Riordan

May 22, 2019

News Conference News EuroPCR 2019

Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements

Shelley Wood

May 16, 2019

News Conference News EuroPCR 2018

NOTION: TAVR in Low-Risk Patients Maintains Its Momentum Through 6 Years

Caitlin E. Cox

May 24, 2018

Presentation EuroPCR 2017

Prosthesis-Related Events and Echocardiographic Data Throughout 9 Years Follow Up After TAVI

Presenter: Luca Testa

May 19, 2017

Presentation EuroPCR 2017

Final five-year Clinical and Echocardiographic Results of Treatment for Severe Aortic Stenosis with a Self-Expanding Bioprosthesis from the ADVANCE Study

Presenter: Ulrich Gerckens

May 17, 2017

News Conference News EuroPCR 2016

‘Signal’ of Poor Durability Seen With First-Generation TAVR Devices

Caitlin E. Cox

May 17, 2016

News Conference News EuroPCR 2014

New Iteration of Sapien Device Associated with Low Rates of Early Mortality, Stroke

L.A. McKeown

May 23, 2014

News Conference News EuroPCR 2013

Deflection Device Reduces Volume, Not Number, of Cerebral Lesions During TAVR

Jason Kahn

May 24, 2013

Advertisement

Myval Noninferior to Other THVs at 1 Year, but Questions Persist

Early TAVI Improves Prognosis in Asymptomatic AS No Matter the Extent of Cardiac Damage

Early outcomes of a randomised non-inferiority trial comparing TAVI devices: the LANDMARK trial

Myval Matches Contemporary TAVI at 30 Days, but Do More Sizes Matter?

Short Methodology Insight - LANDMARK

Up and Away: TAVI Early Discharge Protocols Safely Cut Length of Stay

Five-Year PORTICO IDE Data Reassure on Outcomes, Hemodynamics

Self-Expanding TAVI Valves Offer Best Results in Small Failed Aortic Bioprostheses: LYTEN

Better Durability With Self-Expanding TAVI? Clues From UK TAVI

Changes in Cardiac Damage After AVR Tied to 2-Year Outcomes

Novel Ultrasound Therapy Shows Promise for Patients Unfit for TAVR, SAVR

Allegra TAVR System Feasible for Treating Degenerated Surgical Valves

Longer Follow-up ‘Reassuring’ for New-Onset LBBB After TAVR—With Caveats

Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements

NOTION: TAVR in Low-Risk Patients Maintains Its Momentum Through 6 Years

Prosthesis-Related Events and Echocardiographic Data Throughout 9 Years Follow Up After TAVI

Final five-year Clinical and Echocardiographic Results of Treatment for Severe Aortic Stenosis with a Self-Expanding Bioprosthesis from the ADVANCE Study

‘Signal’ of Poor Durability Seen With First-Generation TAVR Devices

New Iteration of Sapien Device Associated with Low Rates of Early Mortality, Stroke

Deflection Device Reduces Volume, Not Number, of Cerebral Lesions During TAVR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content